Dr Karin Hellner
|Tel||+44 (0)1865 221021|
|Fax||+44 (0)1865 769141|
Fellowships & Awards
- 2000 - 2001: PhD student fellowship by the Charite - Medical Faculty, Humboldt-University of Berlin
- 2007 - 2008: Postdoctoral Research Fellowship by the German Research Foundation (DFG) for basic research at Harvard Medical School Boston, USA
- 2010: DNA Tumor Virus Conference Grant
- 2010: Brigham & Women's Hospital Peer Mentor Award
- 2015: Oxford University Clinical Academic Graduate School (OUCAGS) Career Development Grant
- 2015: OUCAGS Travel Grant for Clinical Lecturers
- Locum Consultant Gynaecologist and Colposcopist
- Clinical Lead for Colposcopy
- Lead for Cervical Sample Taker Register at Oxford University Hospitals NHS Foundation Trust
- UK Chief Investigator and Oxford Principal Investigator for REVEAL-01 Trial (therapeutic HPV vaccine VGX-3100)
Biography & Research
I received my medical degree from the Humboldt-University of Berlin in 2003 and split my specialist training between the Charité - Universitätsmedizin Berlin, Germany, and Oxford University Hospitals NHS Trust, in the UK. I obtained my CCT in February 2015.
In 2007, I interrupted my clinical training and spent 4 years as a postdoctoral research fellow at Harvard Medical School / Brigham & Women's Hospital in Boston, USA, where I have been working on the molecular mechanisms of human papillomavirus (HPV) associated carcinogenesis and drug discovery strategies for cervical cancer.
I joined the University of Oxford as a clinical lecturer in 2011 to work with Prof. Ahmed A. Ahmed at the Weatherall Institute of Molecular Medicine. Since 2015 I am working with Prof. Zondervan's and Prof. Becker's EndoCaRe (Endometriosis Care and Research) team to apply my expertise in the field of reproductive disease.
I have a strong clinical interest in HPV associated cervical disease and was recently appointed as clinical lead consultant for colposcopy at Oxford University Hospitals NHS Foundation Trust.
Recent advances in understanding and preventing human papillomavirus-related disease
Hellner K. and Dorrell L., (2017), F1000 Research
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells.
Taylor C. et al, (2017), Oncotarget, 8, 17960 - 17980
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.
Hellner K. et al, (2016), EBioMedicine
Evaluation Of the Monocyte To Lymphocyte Ratio As a Predictive Marker in Endometriosis Patients.
Hellner K. et al, (2016), REPRODUCTIVE SCIENCES, 23, 327A - 327A
Viral perturbations of host networks reflect disease etiology.
Gulbahce N. et al, (2012), PLoS Comput Biol, 8